Global PDX Models Market by Type, Tumor Type( Mice Models and Rat Models), Application (Preclinical Drug Development, Basic Cancer Research, Biomarker Analysis), End User, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025

  • Publish Date: Jan, 2019
  • Report ID: 362202
  • Category: Healthcare
  • Pages: 0
$4700

Global PDX models market is expected to reach USD 290.14 million by 2025, at a CAGR of 17.51% from 2018 to 2025. The key contributing factors for the market growth are increasing demand of personalised medicine, growth in pharmaceutical sector and growing experimental activities in the area of cancer research.

Market Overview:

PDX models are used to create a resembling situation for the study of natural growth of cancer progression and treatment. Growing demand for customized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry are major factors driving the growth of the market. The growing use of humanized PDX models is also cost effective for the market. PDX models are better than traditional cell line xenograft models because they resemble to the tumors found in actual patients. Rising partnership among players to provide better models is positively affecting the growth of the market. For instance, In May 2017, CRL International, Inc. partnered with OcellO, in which, CRL would be utilizing the latter’s PDX model capabilities in order to expand their oncology based drug discovery service portfolio.

Report Description:

  • The base year for the study has been considered 2017, historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The PDX models market is analysed on the basis of value (USD Million).
  • The study delivers a comprehensive analysis of global PDX models market by type, tumor type, application, end user, and regions.
  • The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the global PDX models market. This report incorporates the industry analysis which is focused on providing an extensive view of the PDX models market.
  • The study also includes attractiveness analysis of type, tumor type, application, end user, and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the PDX models market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • Increasing demand of personalised medicine
  • Growth in pharmaceutical activities
  • Increased efforts for cancer research from the private and public institutions

Restraints:

  • Ethical issues and stringent guidelines regarding usage of animals for cancer research
  • High cost associated with the production of PDX models

Opportunities:

  • Increasing demand for humanized PDX models

Challenges:

  • Limitations of PDX models systems

Global PDX Models Market Key Findings:

All the segments have been analysed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment.

Segmentation Analysis:

The PDX models market is segmented on the basis of type, tumor type, application and end user.

  • The type segment is classified into mice models and rat models. The rat models segment is projected to grow with the highest CAGR of 19.2% in the forecast period. Growth in this market is mainly driven by the larger size of rats, which enhances surgical manipulation. The development of immune-deficient rats will drive the usage of rat models in PDX model generation which is a major contributing factor in the growth of segment.
  • The tumor type segment is classified into gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models and other tumor models.  The gastrointestinal tumor models segment is further sub divided into colorectal, pancreatic, hepatic, and cholangio tumors. The gynecological tumor models segment is further sub divided into breast, ovarian, and cervical tumors. The respiratory tumor model segment is further sub segmented into lung tumors, nasopharyngeal, and bronchial tumors. The urological tumor models segment is sub divided into renal, prostate, and bladder tumors. The hematological tumor Models is sub divided into leukemia and lymphoma. The other tumor models segment is sub divided into head & neck cancer, sarcoma, and melanoma. Gastrointestinal tumor models segment held the largest share of 33.61% in 2017 due to increasing focus of market players on generating lung cancer PDX models, as lung cancer is the leading cause of cancer-related deaths across the globe.
  • Application segment is divided into segments such as preclinical drug development, basic cancer research and biomarker analysis. The preclinical drug development and basic cancer research segment is dominating the market with the market value of USD 41.37 million in 2017. Growth in this segment is mainly driven by the increasing number of research activities in the field of oncology drug research. 
  • End user segment includes pharmaceutical & biotechnology, contract research organizations and academic & research institutions. The pharmaceutical and biotechnology companies segment held the largest share of 42.47% in the patient derived xenograft models market in 2017. The large share of this segment is due to the increasing expenditure on R&D by companies for drug development.

Regional Segmentation Analysis:

The regions analysed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. North America region dominated the global PDX models market with USD 41.3 million in 2017 where as the Asia Pacific region is growing at the highest CAGR in the forecast period.

  • North America is the fastest growing region due to growth in biomedical research, rising preclinical activities by CROs and pharmaceutical companies, and growing stem cell research in Canada.
  • Asia Pacific region is estimated to grow at the highest CAGR during the forecast period, due to strong research expenditure and the well-structured CRO industry in China, rising pharmaceutical R&D expenditure in India, and rising biomedical research in Singapore.

Global PDX Models Market Competitive Analysis:

Key players in the PDX models market are The Jackson Laboratory, Crown Bioscience Inc, Champions Oncology, Inc., WuXi AppTec, ONCODESIGN, EPO Berlin-Buch GmBH, Charles River Laboratories International, Inc., Shanghai LIDE Biotech Co., Ltd, Horizon Discovery Group PLC, Xentech, Explora BioLabs, Urolead, EUROPDX, MI Bioresearch Inc, Aragen Bioscience and others. Various new players and collaboration of existing players is driving the growth. For instance, EVOTEC has collaborated with Inserm and various other research organizations across Europe. In 2015, Cellaria Biosciences and Taconic Biosciences partnered to promote development and higher use of PDX xenograft models. Other strategic plans include development of new databases and PDX based models to serve the current unmet needs. In February 2017, Crown Biosciences launched their advanced digital platform for their oncology database “OncoExpress”.

*All our reports are customizable as per customer requirements

Scope

Key Points

Information

Evaluate Market Potential

Growth Rates (CAGR %)

Value (USD Million) {Market Size}

USP of Report

Industry and Technology Trends

Company Share Analysis

Competitive & Vendor landscape

SWOT Analysis of Each Company

Profit Margin Analysis

Analysis of More than 30 Countries for Each Segment

Base Year

2017

Historical Years

2015-2016

Forecast Period

2018-2025

Regional Analysis

North America, Europe, Asia Pacific, South America, and Middle East and Africa

Countries Analysis

U.S., Canada, Mexico, Germany, France, Sweden, Netherlands, U.K., Italy, Spain, Turkey, Switzerland, Belgium, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Brazil, Saudi Arabia, UAE, Egypt, Nigeria, South Africa

 

This study forecasts revenue and volume growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global PDX models market on the basis of below mentioned segments:

Global PDX Models Market, By Type:

  • Mice Models
  • Rat Models

Global PDX Models Market, By Tumor Type:

  • Gastrointestinal Tumor Models
    • Colorectal Tumor
    • Pancreatic  Tumor
    • Hepatic Tumor
    • Cholangio Tumor
  • Gynecological Tumor Models
    • Breast Tumor
    • Ovarian Tumor
    • Cervical Tumor
  • Respiratory Tumor Models
    • Lung Tumor
    • Nasopharyngeal Tumor
    • Bronchial Tumor
  • Urological Tumor Models
    • Renal Tumor
    •  Prostate Tumor
    • Bladder Tumor
  • Hematological Tumor Models
    • Leukemia 
    •  Lymphoma

Global PDX Models Market, By Application:

  • Pre-clinical drug development and basic cancer research
  • Biomarker analysis

Global PDX Models Market, By End User:

  • Pharmaceutical & biotechnology companies
  • Contract research organizations
  • Academic & research institutions

Global PDX Models Market, By Regions:

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Sweden
  • Netherlands
  • U.K.
  • Italy
  • Spain
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of Asia-Pacific
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of  Middle East and Africa
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
    4. Currency
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market attractiveness analysis by type
      2. Market attractiveness analysis by tumor type
      3. Market attractiveness analysis by application
      4. Market attractiveness analysis by end user
      5. Market attractiveness analysis by region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing demand of personalised medicine
      2. Growth in pharmaceutical activities
      3. Increased efforts for cancer research from the private and public institutions
    3. Restraints
      1. Ethical issues and stringent guidelines regarding usage of animals for cancer research
      2. High cost associated with the products of PDX models
    4. Opportunities
      1. Increasing demand for humanized PDX models
    5. Challenges
      1. Limitations of PDX models systems
  6. Global PDX Models  Market Analysis and Forecast, By Type
    1. Segment Overview
    2. Mice Models
  7. Rat Models
  8. Global PDX Models  Market Analysis and Forecast, By Tumor Type
    1. Segment Overview
    2. Gastrointestinal Tumor Models
      1. Colorectal Tumor
      2. Pancreatic  Tumor
      3. Hepatic Tumor
      4. Cholangio Tumor
    3. Gynecological Tumor Models
      1. Breast Tumor
      2. Ovarian Tumor
      3. Cervical Tumor
    4. Respiratory Tumor Models
      1. Lung Tumor
      2. Nasopharyngeal Tumor
      3. Bronchial Tumor
    5. Urological Tumor Models
      1. Renal Tumor
      2. Prostate Tumor
      3. Bladder Tumor
    6. Hematological Tumor Models
      1. Leukemia
      2. Lymphoma
      3. Bladder Tumor
  9. Global PDX Models  Market Analysis and Forecast, By Application
    1. Segment Overview
    2. Pre-clinical drug development and basic cancer research
    3. Biomarker analysis
  10. Global PDX Models  Market Analysis and Forecast, By End Users
    1. Segment Overview
    2. Pharmaceutical & biotechnology companies
    3. Contract research organizations
    4. Academic & research institutions
  11. Global PDX Models Market Analysis and Forecast, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. Sweden
      4. Netherlands
      5. U.K.
      6. Italy
      7. Spain
      8. Turkey
      9. Switzerland
      10. Belgium
      11. Rest of Europe
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
      4. South Korea
      5. Australia
      6. Singapore
      7. Malaysia
      8. Thailand
      9. Indonesia
      10. Philippines
      11. Rest of Asia-Pacific
    5. South America
      1. Brazil
      2. Argentina
      3. Colombia
      4. Rest of South America
    6. Middle East and Africa
      1. Saudi Arabia
      2. UAE
      3. Egypt
      4. Nigeria
      5. South Africa
      6. Rest of  Middle East and Africa
  12. Global PDX Models  Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the PDX Models  Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Product Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  13. Company Profiles
    1. The Jackson Laboratory
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. Crown Bioscience Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3. Champions Oncology, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4. WuXi AppTec
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5. ONCODESIGN
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6. EPO Berlin-Buch GmBH
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7. Charles River Laboratories International, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Shanghai LIDE Biotech Co., Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9. Horizon Discovery Group PLC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10. Xentech
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11. Explora BioLabs
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12. EUROPDX
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13. MI Bioresearch Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14. Aragen Bioscience
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Cellaria Biosciences
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global PDX Models  Market, By Type, 2015–2025 (USD Million)
  2. Global Mice Models PDX Models  Market, By Region, 2015–2025 (USD Million)
  3. Global Rat Models PDX Models  Market, By Region, 2015–2025 (USD Million)
  4. Global PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  5. Global PDX Models Market, By Gastrointestinal Tumor Models, 2015–2025 (USD Million)
  6. Global PDX Models  Market, By Gynecological Tumor Models, 2015–2025 (USD Million)
  7. Global PDX Models  Market, By Respiratory Tumor Models, 2015–2025 (USD Million)
  8. Global PDX Models  Market, By Urological Tumor Models, 2015–2025 (USD Million)
  9. Global PDX Models  Market, By Hematological Tumor Models, 2015–2025 (USD Million)
  10. Global Gastrointestinal Tumor Models PDX Models  Market, By Region, 2015–2025 (USD Million)
  11. Global Gynecological Tumor Models PDX Models  Market, By Region, 2015–2025 (USD Million)
  12. Global Respiratory Tumor Models PDX Models  Market, By Region, 2015–2025 (USD Million)
  13. Global Urological Tumor Models PDX Models  Market, By Region, 2015–2025 (USD Million)
  14. Global Hematological Tumor Models PDX Models  Market, By Region, 2015–2025 (USD Million)
  15. Global PDX Models  Market, By Application, 2015–2025 (USD Million)
  16. Global Pre-clinical drug development and basic cancer research PDX Models  Market, BY Region, 2015–2025 (USD Million)
  17. Global biomarker analysis PDX Models  Market, By Region, 2015–2025 (USD Million)
  18. Global PDX Models  Market, By End User, 2015–2025 (USD Million)
  19. Global pharmaceutical & biotechnology companies PDX Models  Market, By Region, 2015–2025 (USD Million)
  20. Global Contract research organizations PDX Models  Market, By Region, 2015–2025 (USD Million)
  21. Global Academic & research institutions PDX Models  Market, By Region, 2015–2025 (USD Million)
  22. Global PDX Models  Market, By Region, 2015–2025 (USD Million)
  23. Global PDX Models  Market, By North America, 2015–2025 (USD Million)
  24. North America PDX Models  Market, By Type, 2015–2025 (USD Million)
  25. North America PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  26. North America PDX Models  Market, By Application, 2015–2025 (USD Million)
  27. North America PDX Models  Market, By End User, 2015–2025 (USD Million)
  28. U.S. PDX Models  Market, By Type, 2015–2025 (USD Million)
  29. U.S. PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  30. U.S. PDX Models  Market, By Application, 2015–2025 (USD Million)
  31. U.S. PDX Models  Market, By End User, 2015–2025 (USD Million)
  32. Canada PDX Models  Market, By Type, 2015–2025 (USD Million)
  33. Canada PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  34. Canada PDX Models  Market, By Application, 2015–2025 (USD Million)
  35. Canada PDX Models  Market, By End User, 2015–2025 (USD Million)
  36. Mexico PDX Models  Market, By Type, 2015–2025 (USD Million)
  37. Mexico PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  38. Mexico PDX Models  Market, By Application, 2015–2025 (USD Million)
  39. Mexico PDX Models  Market, By End User, 2015–2025 (USD Million)
  40. Europe PDX Models  Market, By Type, 2015–2025 (USD Million)
  41. Europe PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  42. Europe PDX Models  Market, By Application, 2015–2025 (USD Million)
  43. Europe PDX Models  Market, By End User, 2015–2025 (USD Million)
  44. Germany PDX Models  Market, By Type, 2015–2025 (USD Million)
  45. Germany PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  46. Germany PDX Models  Market, By Application, 2015–2025 (USD Million)
  47. Germany PDX Models  Market, By End User, 2015–2025 (USD Million)
  48. France PDX Models  Market, By Type, 2015–2025 (USD Million)
  49. France PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  50. France PDX Models  Market, By Application, 2015–2025 (USD Million)
  51. France PDX Models  Market, By End User, 2015–2025 (USD Million)
  52. Sweden PDX Models  Market, By Type, 2015–2025 (USD Million)
  53. Sweden PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  54. Sweden PDX Models  Market, By Application, 2015–2025 (USD Million)
  55. Sweden PDX Models  Market, By End User, 2015–2025 (USD Million)
  56. Netherlands PDX Models  Market, By Type, 2015–2025 (USD Million)
  57. Netherlands PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  58. Netherlands PDX Models  Market, By Application, 2015–2025 (USD Million)
  59. Netherlands PDX Models  Market, By End User, 2015–2025 (USD Million)
  60. U.K. PDX Models  Market, By Type, 2015–2025 (USD Million)
  61. U.K. PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  62. U.K. PDX Models  Market, By Application, 2015–2025 (USD Million)
  63. U.K. PDX Models  Market, By End User, 2015–2025 (USD Million)
  64. Italy PDX Models  Market, By Type, 2015–2025 (USD Million)
  65. Italy PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  66. Italy PDX Models  Market, By Application, 2015–2025 (USD Million)
  67. Italy PDX Models  Market, By End User, 2015–2025 (USD Million)
  68. Spain PDX Models  Market, By Type, 2015–2025 (USD Million)
  69. Spain PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  70. Spain PDX Models  Market, By Application, 2015–2025 (USD Million)
  71. Spain PDX Models  Market, By End User, 2015–2025 (USD Million)
  72. Turkey PDX Models  Market, By Type, 2015–2025 (USD Million)
  73. Turkey PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  74. Turkey PDX Models  Market, By Application, 2015–2025 (USD Million)
  75. Turkey PDX Models  Market, By End User, 2015–2025 (USD Million)
  76. Switzerland PDX Models  Market, By Type, 2015–2025 (USD Million)
  77. Switzerland PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  78. Switzerland PDX Models  Market, By Application, 2015–2025 (USD Million)
  79. Switzerland PDX Models  Market, By End User, 2015–2025 (USD Million)
  80. Belgium PDX Models  Market, By Type, 2015–2025 (USD Million)
  81. Belgium PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  82. Belgium PDX Models  Market, By Application, 2015–2025 (USD Million)
  83. Belgium PDX Models  Market, By End User, 2015–2025 (USD Million)
  84. Asia Pacific PDX Models  Market, By Type, 2015–2025 (USD Million)
  85. Asia Pacific PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  86. Asia Pacific PDX Models  Market, By Application, 2015–2025 (USD Million)
  87. Asia Pacific PDX Models  Market, By End User, 2015–2025 (USD Million)
  88. Japan PDX Models  Market, By Type, 2015–2025 (USD Million)
  89. Japan PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  90. Japan PDX Models  Market, By Application, 2015–2025 (USD Million)
  91. Japan PDX Models  Market, By End User, 2015–2025 (USD Million)
  92. China PDX Models  Market, By Type, 2015–2025 (USD Million)
  93. China PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  94. China PDX Models  Market, By Application, 2015–2025 (USD Million)
  95. China PDX Models  Market, By End User, 2015–2025 (USD Million)
  96. India PDX Models  Market, By Type, 2015–2025 (USD Million)
  97. India PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  98. India PDX Models  Market, By Application, 2015–2025 (USD Million)
  99. India PDX Models  Market, By End User, 2015–2025 (USD Million)
  100. South Korea PDX Models  Market, By Type, 2015–2025 (USD Million)
  101. South Korea PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  102. South Korea PDX Models  Market, By Application, 2015–2025 (USD Million)
  103. South Korea PDX Models  Market, By End User, 2015–2025 (USD Million)
  104. Australia PDX Models  Market, By Type, 2015–2025 (USD Million)
  105. Australia PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  106. Australia PDX Models  Market, By Application, 2015–2025 (USD Million)
  107. Australia PDX Models  Market, By End User, 2015–2025 (USD Million)
  108. Singapore PDX Models  Market, By Type, 2015–2025 (USD Million)
  109. Singapore PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  110. Singapore PDX Models  Market, By Application, 2015–2025 (USD Million)
  111. Singapore PDX Models  Market, By End User, 2015–2025 (USD Million)
  112. Malaysia PDX Models  Market, By Type, 2015–2025 (USD Million)
  113. Malaysia PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  114. Malaysia PDX Models  Market, By Application, 2015–2025 (USD Million)
  115. Malaysia PDX Models  Market, By End User, 2015–2025 (USD Million)
  116. Thailand PDX Models  Market, By Type, 2015–2025 (USD Million)
  117. Thailand PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  118. Thailand PDX Models  Market, By Application, 2015–2025 (USD Million)
  119. Thailand PDX Models  Market, By End User, 2015–2025 (USD Million)
  120. Indonesia PDX Models  Market, By Type, 2015–2025 (USD Million)
  121. Indonesia PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  122. Indonesia PDX Models  Market, By Application, 2015–2025 (USD Million)
  123. Indonesia PDX Models  Market, By End User, 2015–2025 (USD Million)
  124. Philippines PDX Models  Market, By Type, 2015–2025 (USD Million)
  125. Philippines PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  126. Philippines PDX Models  Market, By Application, 2015–2025 (USD Million)
  127. Philippines PDX Models  Market, By End User, 2015–2025 (USD Million)
  128. South America PDX Models  Market, By Type, 2015–2025 (USD Million)
  129. South America PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  130. South America PDX Models  Market, By Application, 2015–2025 (USD Million)
  131. South America PDX Models  Market, By End User, 2015–2025 (USD Million)
  132. Brazil PDX Models  Market, By Type, 2015–2025 (USD Million)
  133. Brazil PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  134. Brazil PDX Models  Market, By Application, 2015–2025 (USD Million)
  135. Brazil PDX Models  Market, By End User, 2015–2025 (USD Million)
  136. Argentina PDX Models  Market, By Type, 2015–2025 (USD Million)
  137. Argentina PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  138. Argentina PDX Models  Market, By Application, 2015–2025 (USD Million)
  139. Argentina PDX Models  Market, By End User, 2015–2025 (USD Million)
  140. Colombia PDX Models  Market, By Type, 2015–2025 (USD Million)
  141. Colombia PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  142. Colombia PDX Models  Market, By Application, 2015–2025 (USD Million)
  143. Colombia PDX Models  Market, By End User, 2015–2025 (USD Million)
  144. Middle East and Africa PDX Models  Market, By Type, 2015–2025 (USD Million)
  145. Middle East and Africa PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  146. Middle East and Africa PDX Models  Market, By Application, 2015–2025 (USD Million)
  147. Middle East and Africa PDX Models  Market, By End User, 2015–2025 (USD Million)
  148. Saudi Arabia PDX Models  Market, By Type, 2015–2025 (USD Million)
  149. Saudi Arabia PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  150. Saudi Arabia PDX Models  Market, By Application, 2015–2025 (USD Million)
  151. Saudi Arabia PDX Models  Market, By End User, 2015–2025 (USD Million)
  152. UAE PDX Models  Market, By Type, 2015–2025 (USD Million)
  153. UAE PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  154. UAE PDX Models  Market, By Application, 2015–2025 (USD Million)
  155. UAE PDX Models  Market, By End User, 2015–2025 (USD Million)
  156. Egypt PDX Models  Market, By Type, 2015–2025 (USD Million)
  157. Egypt PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  158. Egypt PDX Models  Market, By Application, 2015–2025 (USD Million)
  159. Egypt PDX Models  Market, By End User, 2015–2025 (USD Million)
  160. Nigeria PDX Models  Market, By Type, 2015–2025 (USD Million)
  161. Nigeria PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  162. Nigeria PDX Models  Market, By Application, 2015–2025 (USD Million)
  163. Nigeria PDX Models  Market, By End User, 2015–2025 (USD Million)
  164. South Africa PDX Models  Market, By Type, 2015–2025 (USD Million)
  165. South Africa PDX Models  Market, By Tumor Type, 2015–2025 (USD Million)
  166. South Africa PDX Models  Market, By Application, 2015–2025 (USD Million)
  167. South Africa PDX Models  Market, By End User, 2015–2025 (USD Million)

 

List of Figures 

  1. Global PDX Models  Market Segmentation
  2. PDX Models  Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-Down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Global PDX Models  Market attractiveness analysis by Type
  9. Global PDX Models  Market attractiveness analysis by Tumor Type
  10. Global PDX Models  Market attractiveness analysis by Application
  11. Global PDX Models  Market attractiveness analysis by Region
  12. Global PDX Models  Market: Dynamics
  13. Global PDX Models  Market Share by Types (2017 & 2025)
  14. Global PDX Models  Market Share by Tumor Types (2017 & 2025)
  15. Global PDX Models  Market Share by Application (2017 & 2025)
  16. Global PDX Models  Market Share by End User (2017 & 2025)
  17. Global PDX Models  Market Share by Regions (2017 & 2025)
  18. Global PDX Models  Market Share by Company (2018)

1

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


+1

Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.